Breath and barking present a breakthrough in cancer diagnosis

SpotitEarly has developed a novel cancer detection method using dogs’ superior olfactory abilities to identify lung, prostate, colorectal, and breast cancers from human breath samples. The company combines canine scent detection with AI-powered sensors to analyze volatile organic compounds (VOCs) in exhaled breath, enabling non-invasive early diagnosis. CEO Shlomi Madar highlights the approach’s potential to revolutionize population health by improving early cancer detection rates through scalable, low-cost screening. This hybrid biological-technological system leverages dogs’ trained scent discrimination while AI enhances accuracy and standardizes results for clinical use. The innovation, presented in February 2026, targets high-mortality cancers, aiming to reduce late-stage diagnoses and improve patient outcomes through proactive screening.